These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26818046)

  • 21. Treatment of status epilepticus with zonisamide: A multicenter cohort study of 34 patients and review of literature.
    Hubert K; Knake S; Bauer S; Voss M; Rosenow F; Strzelczyk A
    Epilepsy Behav; 2020 Aug; 109():107139. PubMed ID: 32417381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retention rate of zonisamide in intractable epilepsy.
    Nakken KO; Lindstrøm P; Andersen H
    Acta Neurol Scand; 2015 May; 131(5):268-74. PubMed ID: 25644477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
    Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
    Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zonisamide in the management of epilepsy in the elderly.
    Romigi A; Femia EA; Fattore C; Vitrani G; Di Gennaro G; Franco V
    Clin Interv Aging; 2015; 10():931-7. PubMed ID: 26089654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study.
    Coppola G; Grosso S; Verrotti A; Parisi P; Luchetti A; Franzoni E; Mangano S; Pelliccia A; Operto FF; Iannetti P; Curatolo P; Balestri P; Pascotto A
    Epilepsy Res; 2009 Feb; 83(2-3):112-6. PubMed ID: 19081227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective audit of adjunctive zonisamide in an everyday clinical setting.
    Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ
    Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of zonisamide in Thai children and adolescents with intractable seizures.
    Thampratankul L; Khongkhatithum C; Visudtibhan A
    J Child Neurol; 2015 Mar; 30(4):527-31. PubMed ID: 25246299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zonisamide: review of pharmacology, clinical efficacy, tolerability, and safety.
    Kothare SV; Kaleyias J
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):493-506. PubMed ID: 18433351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zonisamide as adjunctive therapy for refractory partial seizures.
    Brodie MJ
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy.
    Wellmer J; Wellmer S; Bauer J
    Acta Neurol Scand; 2009 Apr; 119(4):233-8. PubMed ID: 19053955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zonisamide: a new antiepileptic drug.
    Oommen KJ; Mathews S
    Clin Neuropharmacol; 1999; 22(4):192-200. PubMed ID: 10442247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and tolerability of zonisamide in children with epilepsy: a retrospective review.
    Tan HJ; Martland TR; Appleton RE; Kneen R
    Seizure; 2010 Jan; 19(1):31-5. PubMed ID: 19942456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of coadministered antiepileptic drugs on serum zonisamide concentrations in epileptic patients: quantitative analysis based on suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2003 Dec; 26(12):1734-8. PubMed ID: 14646181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of infantile spasms with zonisamide.
    Yanai S; Hanai T; Narazaki O
    Brain Dev; 1999 Apr; 21(3):157-61. PubMed ID: 10372900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticonvulsant effects of zonisamide and phenytoin on seizure activity of the feline visual cortex.
    Wada Y; Hasegawa H; Okuda H; Yamaguchi N
    Brain Dev; 1990; 12(2):206-10. PubMed ID: 2360698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot Study.
    Maschio M; Dinapoli L; Zarabla A; Maialetti A; Giannarelli D; Fabi A; Vidiri A; Cantelmi T
    Clin Neuropharmacol; 2017; 40(3):113-119. PubMed ID: 28452903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L
    Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.